
Managed Care Approaches to ESR1-Mutated Advanced Breast Cancer
Tuesday, May 19, 2026 at 12pm ET Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
Program Description
Join managed care oncology experts and patient advocacy leader for an insightful deep dive into the evolving management of ER+/HER2-mBC. This program delivers exclusive market insights from a multidisciplinary forum, revealing why 100% of polled payers prioritize progression-free survival (PFS) and the critical role companion diagnostics play in timely treatment access. Participants will discover actionable best practices for screening social determinants of health to minimize care disparities, aligning medical and pharmacy benefits to remove patient cost barriers, and leveraging artificial intelligence to streamline complex clinical data. Attendees will also explore the need for comprehensive care programs to improve tolerability and outcomes for both patients and caregivers.
Speaker:
Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO
Director of Pharmacy, Minnesota Oncology
Assistant Professor of Pharmacy, Mayo College of Medicine
Associate Editor, JADPRO
Price
By registering for this event, you agree not to use any form of artificial intelligence (AI) technology to record, transcribe, or reproduce educational sessions, presentations, or discussions in any format.
Click here for more information on AMCP membership or email memberservices@amcp.org.
Required Hardware/software
AMCP Learn utilizes the Zoom Webinars platform for live webinars. For a smoother experience joining the webinar, please install the Zoom desktop client or mobile app prior to the start time. If you experience technical issues joining the webinar, please email webinars@amcp.org.

Facebook
X
LinkedIn
Forward